Date: Wednesday, June 25, 2025
Time: 1:00 PM – 7:00 PM
Location: UC Berkeley
Registration Fee: A registration fee of $40 USD is required upon acceptance to confirm your participation in the event. Registered attendees of the main CHIL conference will pay a reduced fee of $20 USD.
View Schedule
The Health AI Builders: A CHIL Unconference is a unique gathering, held as part of the AHLI Conference on Health, Inference and Learning (CHIL) — an event designed specifically for entrepreneurs building AI-first companies in healthcare. We’re bringing together experienced founders, cutting-edge thinkers, and top experts across regulatory, sales, technology, and fundraising—to help entrepreneurs build category defining business in healthcare. Highlights include:
Stories from entrepreneurs who built from 0 to exit
Insightful talks on the forefront of AI technology and applied uses in healthcare
Intimate, small-group conversations with experts who have been in the trenches with startups and can speak to
Regulatory environment around AI
Building trustworthy technology
Early stage sales for AI products
Early stage fundraising
A community of ambitious, like-minded founders ready to share, support, and collaborate.
If you’re building in healthcare AI, we welcome you to join the community and the conversation. Come with your questions and leave with inspiration and clarity for your startup.
Ron Alfa is a physician scientist at the forefront of leveraging technology to tackle unmet therapeutic needs in medicine. He is Co-Founder and CEO of NOETIK, a next generation precision oncology company using multimodal foundation models pre-trained on large-scale human tumor data to discover cancer therapeutics. Prior to founding Noetik, Ron was Senior Vice President, Head of Research and acting-CSO at Recursion, where he led the company’s scientific organizations and portfolio strategy. Ron holds an MD and PhD from Stanford University School of Medicine, where he completed his doctoral work in Neuroscience, and has a MA in History of Medicine from UCL.
John Axerio-Cilies is Chief Data Technology Officer at Tempus AI, leading data platform and engineering teams focused on scalable, secure, and efficient systems to advance Tempus’s commercial data strategy and applications. Previously, as SVP and Head of AI Apps Engineering, he oversaw product and engineering in genomics algos, digital pathology, radiology, cardiology, and generative AI, integrating diverse data types to address disease-specific care gaps and support clinical trial enrollment. Earlier roles included General Manager of Radiology at Tempus, where he combined medical imaging with clinical and molecular data to support multimodal precision medicine, and CEO and co-founder/CTO of Arterys, where he and his team pioneered groundbreaking AI innovations such as 4D Flow MRI, cloud-native 4D rendering and the first FDA cleared deep learning algorithm in healthcare.
Hong is a Principal at Define Ventures, an early-stage healthcare focused venture fund with $800M under management. Hong’s career spans multi sectors within healthcare, sitting at the intersection of the traditional healthcare system and venture capital and entrepreneurship. She started her career in the life sciences practice at Analysis Group, one of the largest economic consulting firms in the country, then went into a number of strategic investing roles at leading healthcare payer and provider institutions like Kaiser Permanente, Cedar Sinai Health System and the California HealthCare Foundation.
Dr. Nikesh Kotecha is a senior leader in biomedical informatics and a seasoned entrepreneur driving innovation in cancer immunotherapy. As Vice President of Informatics at the Parker Institute for Cancer Immunotherapy (PICI), he spearheads the integration of computational and molecular technologies to accelerate the development of transformative immune-based treatments. He co-founded Cytobank Inc., a pioneering company in single-cell proteomics and cytometry analytics. Dr. Kotecha holds a Ph.D. in Biomedical Informatics from Stanford University and a B.S. in Biomedical Engineering from Boston University. His career spans roles in engineering, business development, and technical leadership at organizations including TIBCO Spotfire and Pfizer.
Fereshteh Mahvar is a Staff Medical Software Engineer and Cloud Solutions Architect at Google Research, where she currently plays a technical lead role in translating health AI research to open solutions via goo.gle/hai-def. Prior to her current role, she played a lead role in developing software-as-a-medical-device (SaMD) investigational products for Google Health. She has played a role in multiple clinical studies such as breast cancer screening triage at Northwestern Medicine, automating second reading in the NHS breast cancer screening program and organ contouring for radiation oncology treatment planning at Mayo Clinic. With 20 years of prior industry experience, she began her Google career in 2017 as a Solutions Architect in Google Cloud, providing guidance to large enterprises on their cloud adoption and developing industry blueprints for big data and machine learning.
Sunita Mohanty is the co-founder and CEO of Vibrant Practice, the OS for modern medical practices. She was previously a product leader at Meta, where she led teams for Oculus and AI for Meta Ray-Bans. Her work bridges the gap between cutting-edge technology and the human side of healthcare.
